Early detection, the most effective tool for colon cancer

Within the framework of World Colon Cancer Day, which was celebrated last Sunday, March 31, specialists from the High-Risk Colorectal Cancer Unit of the Motoa Terrassa University Hospital explain to us the importance of following the screening program in the early stage of colorectal cancer, promoted by the Catalan Health Service.

As Laura Ruiz, gastroenterologist in charge of the high-risk colorectal cancer unit at MútuaTerrassa, explains, colorectal cancer is a common disease among men and women over the age of 50. It often develops from small lesions within the intestine (benign polyps), which can eventually turn into malignant polyps and thus cancer. If caught early, it is much easier to treat and has a better chance of recovery.

The program is intended for all people, men and women, between the ages of 50 and 69 years. It consists of performing a simple test at home every two years to detect the possible presence of small amounts of blood in the stool. These blood spots may not be noticed with the naked eye, but early detection using this test can be crucial for preventing and treating colorectal cancer.

Message with instructions

In order for people living in one of the areas where the initiative has already been launched to be able to participate in the program, they will receive a letter with instructions to follow to take the test. The final result will be sent via mail or phone in the following weeks.

If the test results indicate that everything is within normal limits, your chances of developing colorectal cancer are very low. However, if you experience any digestive symptoms, it is recommended to consult a doctor. If the test detects blood marks, explained Mar Pugales, a nurse at the high-risk colorectal cancer unit at Motua Terrassa, it is likely to be a benign lesion. In this case, a gastrointestinal endoscopy will be suggested under anesthesia, allowing the entire interior of the colon and rectum to be seen. Although it is an invasive screening, the test presents a very low risk of complications and is crucial for the prevention and treatment of colorectal cancer, as it allows the removal of potentially malignant polyps as well as the treatment of lesions that are already malignant.